• Dronedarone (Multaq) in KCa2 Channel Research

  2026-09-24

  Use Dronedarone (Multaq) to test a clinically relevant antiarrhythmic in atrial-cell workflows without assuming it blocks every proposed atrial target. A key patch-clamp study found that dronedarone did not emerge as a meaningful KCa2.2 or KCa2.3 inhibitor, making it a useful comparator for target-selectivity and assay-validation studies.

• I-BET151 and the Enhancer Logic of Disulfidptosis

  2026-09-23

  Explore how I-BET151 (GSK1210151A) can help test whether BET-dependent transcription contributes to the FOXA1–SLC7A11 axis in prostate cancer. This article interprets recent disulfidptosis findings while distinguishing evidence from experimental hypotheses.

• 3-Aminobenzamide (PARP-IN-1) Research Workflows

  2026-09-23

  Build controlled PARP inhibition experiments across oxidative-stress, endothelial, renal, and innate-immunity models. This guide distinguishes product specifications from workflow starting points and translates coronavirus macrodomain findings into practical assay controls.

• I-BET151 (GSK1210151A) Assay Guide

  2026-09-22

  A scenario-based guide to using I-BET151 (GSK1210151A), SKU B1500, in viability, apoptosis, proliferation, and cell-cycle studies. It connects BET biology with practical stock preparation, assay controls, interpretation, and evidence-based reagent selection.

• Acifran: HCAR Agonist for Lipid Research

  2026-09-22

  Acifran is the research compound (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid and a selective agonist of HM74A/GPR109A and GPR109B. Recent cryo-EM work defines how acifran engages HCAR2 and HCAR3, supporting its use in lipid signaling pathway modulation and receptor-selectivity studies.

• Dual Luciferase Reporter Gene System: Stress Assays

  2026-09-21

  The Dual Luciferase Reporter Gene System offers a rigorous way to separate promoter activation from experimental noise in stress-response research. This guide applies dual-reporter logic to the SlSTOP1–SlSLAH1–SlSLAH2 pathway in tomato while defining practical limits for plant applications.

• DiscoveryProbe FDA-approved Drug Library: Assay Logic

  2026-09-21

  Learn how the DiscoveryProbe FDA-approved Drug Library can support mechanism-aware drug repositioning screening. Using norovirus–NINJ1 biology as a model, this article shows how orthogonal readouts turn phenotypic hits into testable pharmacological hypotheses.

• HyperTrap Heparin HP Column for Stemness Research

  2026-09-20

  Use the HyperTrap Heparin HP Column to enrich soluble heparin-binding proteins, growth factors, and pathway-associated cofactors while keeping CCR7–Notch1 measurements analytically separate. Its fine-particle HyperChrom Heparin HP Agarose format supports high-resolution fractionation, scalable loading, and practical cleanup of complex biological samples.

• Ivermectin Beyond the Label: Translational Assay Strategy

  2026-09-19

  Ivermectin is best understood not only as an established broad-spectrum anti-parasitic, but also as a disciplined reference compound for translational assay design. This article connects its parasitology utility with the mechanistic lessons of Gasdermin C biology in pancreatic cancer without overstating unproven oncology activity.

• Dronedarone: Atrial Assay Interpretation Guide

  2026-09-18

  Dronedarone (Multaq) is more than a broad-spectrum antiarrhythmic comparator: its apparent lack of direct KCa2.2/KCa2.3 inhibition can sharpen assay design. This guide translates automated patch-clamp evidence, chemical handling data, and target-deconvolution principles into better atrial fibrillation treatment research.

• ZNF263, ULK1 Autophagy, and ICC Proliferation

  2026-09-18

  This study identifies ZNF263 as a transcriptional driver of intrahepatic cholangiocarcinoma (ICC) proliferation and links its activity to enhancer-mediated activation of ULK1 and autophagy. By combining genomic occupancy mapping, transcriptomics, reporter assays, cellular phenotyping, and xenograft analysis, the authors define a ZNF263–ULK1 axis with potential prognostic and therapeutic relevance.

• Ivermectin Workflows for Parasitology Research

  2026-09-17

  Build more reproducible parasite assays with Ivermectin by controlling solvent, concentration, exposure time, and orthogonal readouts. This guide also shows how a Gasdermin C cancer study can improve assay logic without implying that Ivermectin is an oncology treatment or GSDMC inhibitor.

• A-1210477: MCL-1 Inhibitor Workflow

  2026-09-17

  A-1210477 enables mechanism-focused studies of MCL-1-dependent cancer cell survival, from BIM displacement to mitochondrial apoptosis. This practical guide covers compound handling, dose-response design, apoptosis readouts, combination experiments, and troubleshooting for reproducible cancer research.

• Norepinephrine Bitartrate in Translational Research

  2026-09-16

  A mechanistic and strategic guide to using (-)-Norepinephrine (+)-bitartrate for adrenergic receptor signaling, cardiovascular models, binding studies, and translational research design.

• AO/PI Double Staining Kit for Cell Fate Analysis

  2026-09-16

  The AO/PI Double Staining Kit distinguishes viable, apoptotic, and necrotic cells in one rapid fluorescent workflow. It is especially useful for treatment-response studies, including melanoma experiments where apoptosis findings benefit from orthogonal biochemical and morphological validation.

8376 records 1/559 page Next 12345 下5页 Last page